GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Dec 31, 2021

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-22-000006General Corporate
Capex intensity15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.37% · OPTIONAL · VALID

Operating cash generation35thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

3.22% · OPTIONAL · VALID

Revenue growth72thOwn-history percentile · N=18
Evidence method

Yoy · gp.fundamentals.revenue

12.58% · CORE · VALID

Gross margin75thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

15.16% · CORE · VALID

Operating margin75thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

5.36% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
0.37%
Current
0.37%
Delta
-0.00%
Cash Generation Decreased
Previous
4.79%
Current
3.22%
Delta
-1.58%
Growth Decreased
Previous
14.53%
Current
12.58%
Delta
-1.95%
Margin Increased
Previous
15.12%
Current
15.16%
Delta
0.04%
Profitability Decreased
Previous
5.45%
Current
5.36%
Delta
-0.09%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.